Stanley Goldfarb

This content was last updated March 11, 2024, 10:02 a.m. UTC

Stanley Goldfarb is a conservative nephrologist who has begun building a career opposing transgender care through his organization, Do No Harm, which opposes critical race theory and transgender acceptance in medicine. Writing anti-trans articles for many conservative news outlets, Goldfarb has also appeared on outlets such as Fox News as an expert guest.

In addition to leading Do No Harm, Goldfarb is notable for writing Take Two Aspirin and Call Me By My Pronouns, which features anti-trans talking points in the realm of medicine. He has also worked with Do No Harm to help draft legislation used across the country that attempts to ban transgender healthcare.

Yet America is doubling down on invasive and irreversible medical interventions for minors at steadily younger ages — with rare exceptions like Utah, which just banned such treatments this weekend.  Blame radical gender ideology, which blinds American activists to medical reality and the true needs of vulnerable children.

Goldfarb for the New York Post, 30 January 2023

Education and Credentials

Goldfarb earned his Doctor of Medicine degree in 1969 from the University of Rochester’s Medicine School, where he specialized in nephrology. Career highlights include serving as an Associate Dean at UPenn, a role he retired from in 2019. Goldfarb retains a professor emeritus title at UPenn.

In addition to publishing nephrology research funded by the National Institute of Health, Goldfarb’s profile on Do No Harm’s website describes him as having served on the editorial board of various scientific journals, including the Journal of Clinical Investigation, the Clinical Journal of the American Society of Nephrology, and the journal Diabetes, and as the editor-in-chief of the American Society of Nephrology’s journal NephSAP.

Goldfarb does not have any direct experience with treating gender dysphoria, nor has he published any scientific research on the subject.

Ideological and Institutional Affiliations

The majority of Goldfarb’s work currently consists of activity for his organization, Do No Harm, as the founder and current board chair of the organization.

Anti-Trans Activism

Goldfarb’s anti-trans work began with the publication of his 2022 book “Take Two Aspirin and Call Me By My Pronouns: Why Turning Doctors into Social Justice Warriors is Destroying American Medicine.” While the book primarily opposes anti-racist policies in medicine, it also discusses transgender inclusivity with a tone of disdain.

Goldfarb’s views opposing awareness of racism in medical contexts and the mainstream consensus around gender-affirming medical care have been published in various right-wing outlets, including the New York Post, the Wall Street Journal, and National Review. He has been featured on Fox News as an expert guest as well.

Goldfarb is active on Twitter where he has shown his support for many other figures in anti-trans organizing, including detransitioner Chloe Cole, who works with his organization. Other posts have supported articles that oppose transgender rights.

Court or Legislative Appearances

While Goldfarb has not directly appeared within a legislative context supporting anti-trans bills, he has done work through Do No Harm to push for model legislation targeting trans people’s civil rights. As revealed by the Associated Press, Do No Harm’s model legislation contained  language mirrored in Montana’s Senate Bill 99, Arkansas Senate Bill 199, Iowa Senate File 129, and Mississippi House Bill 1125.

Anti-anti Racism

One of Goldfarb’s core ideological tenets is his promotion of anti-woke medicine. He believes that ‘critical race theory’ harms the medical profession by making doctors aware of racial inequities in the system. 

Further resources:

Contact The Trans Data Library

Contact Us


[('DefinedTerm', 'model legislation'), ('Place', 'Pennsylvania'), ('DefinedTerm', 'research'), ('DefinedTerm', 'activism'), ('DefinedTerm', 'author'), ('DefinedTerm', 'book publishing'), ('Organization', 'Do No Harm'), ('DefinedTerm', 'medical care'), ('DefinedTerm', 'gender-affirming care')]